This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Engineers see everything as a system, know how to design under constraints, and recognize the need for trade-offs. Adopting an engineering mindset in oncology research can fix all the broken constituent processes like patient enrollment to systematize clinical trials.
While the approach to patient and treatment safety is crucial, there is a notable shift towards processes centered around patients and healthcare professionals. The post Beyond Engineering: Integrating UX for Safer and More Efficient Medical Products appeared first on MedCity News.
In a day of vast innovation, expansion, and acquisitions, an engineering mindset can bring a unique and effective approach to thinking across the system, evaluating the current and future state, standardizing on best practices, and considering upstream and downstream workflows.
Novome Biotechnologies — a biotech that CEO Blake Wise says is only company to pursue engineered cell therapy with microbes for the treatment of chronic diseases — raised $43.5 million in Series B funds.
Capstan Therapeutics, a University of Pennsylvania spinout, is now out of stealth with technology that could enable new medicines that work by engineering cells inside of a patient.
revealed the first patient to be dosed with OTX-2002, the first programmable mRNA therapeutic for c-Myc (MYC) oncogene overexpression, which targets cancer cells while sparing healthy cells. Biotech firm Omega Therapeutics, Inc. The investigation is expected to enrol around 190 volunteers in the US, Asia and Europe.
Liver complications are a known side effect risk of Zolgensma and other genetic medicines that are delivered by engineered viruses. The two deaths reported following treatment with Novartis’s Zolgensma mark the first fatal cases of acute liver failure associated with the gene therapy.
Chiesi drug Lamzede is an engineered version of an enzyme that’s lacking in patients with the rare disease alpha-mannosidosis. FDA approval of the Chiesi drug comes about five years after European regulators authorized the product.
We need a streamlined approach where stakeholders can perform all critical tasks — from enrollment and patient consent to prior authorization, from real-time benefit checks to financial assistance — on a central platform powered by a business rules engine, automated workflows, and real-time analytics.
Neuromodulation isn’t just about stimulating nerves; it’s about awakening hope and transforming lives—one patient at a time. In this episode, Blake Williams takes us on a wild journey through his career as a Field Clinical Engineer (FCE), shedding light on the incredible impact of neuromodulation on the lives of patients.
However, even as science advances, there remain patients who still need new treatment options. By re-engineering existing approaches that have already shown clinical promise, there is potential to bring further benefit to the patient community in its fight against cancer.
Forward by Stewart Gandolf, Chief Executive Officer At Healthcare Success, we understand that a patients journey often beings with a search query. Symptom search optimization is crucial for: Guiding patient journeys. These symptom-based searches represent the initial touchpoint in the modern patient acquisition funnel.
For the first time in over a decade, there is a new treatment option for patients with synovial sarcoma, a rare soft tissue cancer. With US approval TECELRA, “there is a renewed sense of hope for this patient community.” The post FDA approves innovative engineered cell therapy appeared first on European Pharmaceutical Review.
Last year, in market research, I heard cancer patients and caregivers talk about the confusion around trying to get credible health information including treatment options. Most often, patients relied on the internet (specifically multiple myeloma websites [94%] and general search engines [92%] to find information about multiple myeloma).
Through the power of large language models and generative AI, pharma and biotech companies are transforming medical information delivery by offering direct, trustworthy, and accurate answers to patients and healthcare providers, significantly reducing time and frustration.
Akili looks like it could bring another digital therapeutic (DTx) to market after a clinical trial backed the efficacy of its AKL-T01 in patients with the autoimmune disorder systemic lupus erythematosus (SLE). The post Akili digital therapeutic shows promise in lupus patients appeared first on.
DTC marketers need to be ready to understand and help patients who request new medications via telehealth or email. This means an in-depth understanding of how HCP’s will react to a new medication request via email or telehealth and how to communicate full expectations to patients.
The authors remarked that one of the main benefits of the proposed new intestinal drug delivery system is that it offers a personalised approach that can be tailored to the needs of patients. Findings from this study were published in Macromolecular Materials and Engineering.
Imagine SEO as a roadmap guiding patients and healthcare professionals to the information they need about your products. Use structured data to make your pages more search-engine-friendly. Educational Content for Patients and Providers: Publish blog posts, white papers, and infographics that address common questions and concerns.
A thirteen-year-old patient with relapsed T-cell acute lymphoblastic leukaemia (T-ALL) has been the first to be treated with base-edited T-cells via CD7 Chimeric Antigen Receptor (CAR)-T cell therapy, which enabled them to achieve remission 28 days later. . Six months later, the patient is doing well and is recovering at home.
The deal focuses on development of in vivo cell therapies, utilising EsoBiotecs Engineered NanoBody Lentiviral (ENaBL) platform. This helps to overcome key challenges in the field, such as cutting manufacturing timelines and improving patient access.
Focused search engines or edited portal sites maintained by professional societies, professional librarians, or other organizations may help to reduce the volume of information retrieved. Any therapy that is not face to face, such as texting, Emailing, and chat, robs patients of a vitally important means of communication.
With the rapid expansion of digital platforms, evolving patient expectations, and the increasing role of AI-driven marketing, pharmaceutical companies and healthcare brands are allocating more resources to advertising in 2025. Patients and healthcare providers are more reliant on online information than ever before.
In recent years there has been significant development within the cell therapy field, as chimeric antigen receptor (CAR) T-cell therapy demonstrated an ability to transform the treatment of patients with haematological malignancies. What are Tregs and how are they applicable to immune-mediated disease?
SUMMARY: With patients staying away from their doctors because of COVID, DTC messages need to add incentives and better messaging to get people to take action rather than wait. My doctor’s office recently sent me an email that they had plenty of telehealth appointments available for patients who didn’t want to come to the office.
The digital landscape has transformed how pharmaceutical brands reach healthcare professionals (HCPs) and patients. Understanding the Basics of Digital Advertising Digital advertising involves promoting your brand online through channels like search engines, social media, and display networks.
The QR code allows hospitals and healthcare providers to satisfy this need with immediate physician-patient interaction and engagement – all through smartphones and tablets. . In this blog post, you’ll learn: Why QR codes have made a comeback, When to use them, And, 8 ways to improve the patient experience and drive leads with QR codes. .
Introduction The pharmaceutical industry faces unique challenges in digital marketing, especially when it comes to reaching healthcare professionals (HCPs) and patients effectively. In pharma marketing, ad retargeting plays a crucial role in educating patients and HCPs about new treatments, clinical trials, and brand offerings.
Ocugen plans to expand the OCU400 clinical trial in the second half of 2024 to include patients with LCA, contingent on favourable results from the Phase I/II study and alignment with regulatory agencies. To date, six patients with Stargardt disease have been dosed in the Phase I/II clinical trial.
As a healthcare practice, your online reputation is crucial to attracting and retaining patients. With the rise of online review platforms, patients have a powerful voice in sharing their experiences with others. Healthcare professionals need to understand and follow patient privacy laws, specifically HIPAA regulations.
When we think of adherence in the medical world, it’s often simplified to something along the lines of the degree to which a patient correctly follows medical advice. It’s a simple statement with many, many moving parts, especially when we’re talking about patients with multiple chronic conditions. So how is this achieved?
CSL announced the first patient with haemophilia B has been treated with its recently approved gene therapy Hemgenix (etranacogene dezaparvovec). In the study, Hemgenix reduced or eliminated the need for prophylactic treatment in 94% of patients. Hemgenix is the first and only gene therapy approved for haemophilia B.
Researchers at Great Ormond Street Hospital for Children (GOSH) and University College London (UCL) Great Ormond Street Institute of Child Health (UCL GOS ICH) have used “universal” CRISPR-edited cells in humans for the first time to treat B-cell acute lymphoblastic leukaemia (B-ALL) child patients with engineered donor T cells.
A successful health system, hospital, practice, or healthcare organization website facilitates patient communication and helps you win more of the patients you want. But this doesn’t mean much if patients can’t find your website. Siloing also helps search engines crawl, index, and rank your website better.
The Engineering and Physical Sciences Research Council (EPSRC) has set aside £400,000 (almost $490,000) for the project, which will help fund work at the Universities of Plymouth, Salford and Stirling, and the Glasgow School of Art. Using 3D cameras and body sensors, patients will be able to see and hear their breathing on screen.
Phreesia and Colorectal Cancer Alliance No Ifs, Ands, or Buts: Point-of-Care Awareness Campaign on Colorectal Cancer Screenings Phreesia and the Colorectal Cancer Alliance partnered to promote screening for early detection of colorectal cancer & patient awareness of colorectal cancer (CRC) prevalence.
In this article, well dive into key pharma digital marketing strategies that can help pharma brands connect with healthcare professionals (HCPs), patients, and stakeholders effectively. Improve patient engagement with valuable content and resources. Without the right strategy, you risk getting lost in a sea of content.
As the healthcare industry continues to evolve, digital marketing strategies, such as search engine optimization (SEO), have become increasingly crucial for healthcare organizations. Search engine optimization sits at the heart of any successful healthcare marketing strategy. What is Search Engine Optimization?
Adrian Rawcliffe, Adaptimmune’s Chief Executive Officer asserted that the combined companies will work to gain “approval for the first engineered T-cell receptor (TCR) T-cell therapy for a solid tumour – afami-cel for the treatment of synovial sarcoma.”
Anne Kerber, Senior Vice President, Cell Therapy Development at Bristol Myers Squibb explained the intention behind developing Abecma: “We sought to deliver a personalised therapy that provides durable outcomes with a single infusion to advance the multiple myeloma treatment paradigm for patients.” Ultimately, this goal proved successful.
It is also the first successful Phase II trial using an engineered cell therapy for autoimmunity. Descartes-08 works by modifying patients’ T-cells with mRNA to express a chimeric antigen receptor (CAR). The RNA cell therapy study for myasthenia gravis There were 14 gMG patients enrolled in the study.
From AI-powered insights to the rise of precision medicine, new trends are reshaping the way we connect with patients and healthcare providers. Whether it’s identifying patient demographics or assessing market needs, research bridges the gap between innovation and engagement.
ElevateBio has entered a partnership with Affini-T Therapeutics to progress the latter’s engineered TCR-T therapies focused on Kirsten rat sarcoma viral oncogene homolog (KRAS), a dominant oncogenic driver mutation in solid tumours.
Glick, said the company is innovating “next generation therapeutics by marrying a powerful drug discovery engine integrating machine learning [ML], biology, and medicinal and structural chemistry with an exceptional leadership of proven drug developers”. Rowe Price Associates, Inc., Odyssey Therapeutics’ founder and CEO, Gary D.
We organize all of the trending information in your field so you don't have to. Join 8,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content